Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sangha Capital is a Geneva-based venture capital investment firm established in 2020. It focuses on investing in purpose-driven technology companies that address global challenges aligned with the United Nations Sustainable Development Goals. The firm invests across sectors including technology, finance, and sustainability—occasionally including life sciences and biotech through its portfolio companies. Sangha Capital is a Geneva-based venture capital investment club founded in 2020 that invests in purpose-driven technology companies addressing global challenges under the UN Sustainable Development Goals framework. While it occasionally backs life science or biotech startups through its portfolio—for example Cocoon Bioscience or Talam Biotechnology—it does not itself develop drugs or healthcare products nor operate as a CRO/CMO/Biotech company. Its main focus areas are technology and finance with additional interest in sustainability-related sectors such as sustainable proteins and agri-biotech via investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sangha Capital.